Groowe Groowe / Newsroom / REGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

REGN News

Regeneron Pharmaceuticals Inc

Canada ICT Market (2026-2031) - Growth Driven by Accelerating Digital Transformation

globenewswire.com
MSFT AMZN CSCO GOOG IBM ORCL CRM SHOP LSPD NOW PANW ZS FTNT CDNS SNPS AMD NVDA INTC MU AMAT LRCX KLAC TEL NXPI ON ADI TXN AEHR TER PLTR AI SMCI DELL HPQ STX WDC REGN GILD BIIB CRSP XOM CVX NEE DUK SO PCG ETSY PYPL QCOM MRVL ADSK CDW ACN CSGS NTAP VRTX MRNA BMY AMGN AZN PFE JNJ GOOGL AAPL META NFLX TSLA GE BA RTX LMT GD HON CAT DE ROKU WIX RCL CCL NCLH ATOS

Global Cell Counting Market to Reach USD 20.5 Billion by 2033 as Automation and AI Adoption Accelerate

globenewswire.com
TMO BDX AMGN GILD REGN BMY MRK DHR BIO GEHC

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

businesswire.com
REGN

Did You Lose Money on Regeneron Pharmaceuticals, Inc. (REGN)? Levi & Korsinsky Urges Investors to Act Before September 14, 2026

accessnewswire.com
REGN

REGN 4-DAY DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

prnewswire.com
REGN

Levi & Korsinsky Urges Regeneron (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026

accessnewswire.com
REGN

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN

prnewswire.com
REGN

REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

globenewswire.com
REGN

Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action

accessnewswire.com
REGN

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN

prnewswire.com
REGN